| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00827
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0472
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00613
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-1425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-327
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-1477
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00761
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00714
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-05 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-1233
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0412 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-05 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B18-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B18-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B18-18 |
| filingDate |
2004-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c936c945c33297cfc0d2e0045155143
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7445fbf6865205b800b909518c03500c |
| publicationDate |
2006-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1696812-A2 |
| titleOfInvention |
Tissue ablation with irreversible electroporation |
| abstract |
A new method for the ablation of undesirable tissue such as cells of a cancerous or non-cancerous tumor is disclosed. It involves the placement of electrodes into or near the vicinity of the undesirable tissue through the application of electrical pulses causing irreversible electroporation of the cells throughout the entire area of the undesirable tissue. The electric pulses irreversibly permeate the cell membranes, thereby invoking cell death. The irreversibly permeabilized cells are left in situ and are removed by the body immune system. The amount of tissue ablation achievable through the use of irreversible electroporation without inducing thermal damage is considerable. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10390874-B2 |
| priorityDate |
2003-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |